Hypothesis

Transient autophagy activation during partial reprogramming supplies the necessary metabolites and subcellular localization for TET enzymes to oxidize 5‑methylcytosine, thereby driving DNA demethylation without triggering pluripotency. When autophagy is inhibited, TET recruitment to chromatin fails, epigenetic age reversal stalls, and cells default to a senescent or maladaptive state despite OSKM expression.

Mechanistic Rationale

1. Autophagy‑derived α‑ketoglutarate (α‑KG) – Lysosomal degradation of amino acids and lipids releases α‑KG, a essential cofactor for TET dioxygenase activity. Recent work shows that autophagy fuels TET‑mediated demethylation during partial reprogramming [1, 2].
2. Selective cargo – Damaged mitochondria – Mitophagy reduces mitochondrial ROS, preventing ROS‑mediated TET inhibition and favorably shifting the NAD⁺/NADH ratio, which further supports TET activity.
3. Spatial coupling – Autophagosomes associate with perinuclear chromatin niches, delivering α‑KG and possibly scaffold proteins (e.g., p62) that tether TET complexes to demethylation sites.

Testable Predictions

• Prediction 1: Pharmacological or genetic blockade of autophagy (e.g., chloroquine, ATG5/7 knockout) during a standard cyclic OSKM pulse will abolish the decline in epigenetic age measured by Horvath’s clock, while OSKM‑induced transcription of pluripotency genes remains unchanged.
• Prediction 2: Supplementation with cell‑permeable α‑KG will rescue the epigenetic age‑reversal defect in autophagy‑deficient cells, restoring demethylation kinetics to control levels.
• Prediction 3: Imaging of TET2‑GFP alongside LC3 puncta will show increased colocalization during the early 24‑48 h window of OSKM exposure; this colocalization will disappear upon autophagy inhibition.

Experimental Approach

• Use murine embryonic fibroblasts (MEFs) from a Rosa26‑LSL‑OSKM inducible line. Apply a 48‑hour doxycycline pulse (cyclic protocol) ± autophagy inhibitor (chloroquine 50 µM) or ATG5 siRNA.
• Measure epigenetic age using the murine multi‑tissue clock at 0, 48, and 96 h post‑pulse.
• Perform bisulfite‑seq to quantify 5‑mC loss at CpG islands associated with aging signatures.
• Assess TET activity via 5‑hmC immunostaining and α‑KG levels via LC‑MS.
• Rescue experiments: add dimethyl‑α‑KG (1 mM) to autophagy‑blocked conditions.
• Confirm specificity by checking Nanog and Sox2 expression to ensure pluripotency entry is not altered.

Potential Impact

If validated, this hypothesis positions autophagy as a metabolic gatekeeper that couples nutrient state to epigenetic remodeling, explaining why intermittent OSKM regimens are safe and effective. It also suggests that combining autophagy inducers (e.g., spermidine, rapamycin low dose) with transient Yamanaka factor exposure could enhance rejuvenation outcomes while minimizing tumorigenic risk.